EGFP mRNA (N1-Me-pseudo U)
EGFP mRNA (N1-Me-pseudo U) - M (Molecular Biology) / 1mg / centrifuge tube is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Details
Details
EGFP mRNA (N1-Me-pseudo U) is a chemically modified messenger RNA molecule capable of expressing enhanced green fluorescent protein (eGFP), and is mainly used for gene expression detection, transfection efficiency evaluation, and protein localization tracking in biomedical research. Through optimization of co-transcription with cap addition, it has high translation efficiency and stability, and is suitable for experiments in cells and animals. Additionally, N1-Me-pseudo U modification enhances translation efficiency and reduces immunogenicity.
Specifications
Specifications
-
Catalog No.ON-278
-
SourceN/A
-
PurityN/A
Documentation
Documentation
EGFP mRNA (N1-Me-pseudo U) is a chemically modified messenger RNA molecule capable of expressing enhanced green fluorescent protein (eGFP), and is mainly used for gene expression detection, transfection efficiency evaluation, and protein localization tracking in biomedical research. Through optimization of co-transcription with cap addition, it has high translation efficiency and stability, and is suitable for experiments in cells and animals. Additionally, N1-Me-pseudo U modification enhances translation efficiency and reduces immunogenicity.
-
Catalog No.ON-278
-
SourceN/A
-
PurityN/A
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.

